Anti-Aging: China vs India

Market size, growth to 2033 and clinical trials, side by side.

China is the bigger Anti-Aging market: $7.1 Bn against $1.6 Bn in 2023, about 4.4 times as large.

India grows faster: 11.1% a year, against 9.6%. The gap still grows from $5.5 Bn to $13.1 Bn by 2033.

Clinical research: 146 active trials in China, 9 in India.

Anti-Aging: China compared with India
Measure China India
Market size, 2023$7.1 Bn$1.6 Bn
Market size, 2033 projected$17.7 Bn$4.6 Bn
Growth a year (CAGR)9.6%11.1%
Money added, 2023–2033$10.6 Bn$3 Bn
Share of the world market8%1.8%
Size rank of 24 countries#2#12
Market per person, 2023$5.04$1.10
Active clinical trials 146 9
Full reportChina report India report

Year by year, 2023 to 2033

China India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.

Quick answers

Which is bigger in Anti-Aging, China or India?

China is the bigger Anti-Aging market: $7.1 Bn against $1.6 Bn in 2023, about 4.4 times as large.

Which grows faster in Anti-Aging, China or India?

India grows faster: 11.1% a year, against 9.6%. The gap still grows from $5.5 Bn to $13.1 Bn by 2033.

More Anti-Aging comparisons

Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.